Pattern of Inflammation on Surveillance Colonoscopy Does Not Predict Development of Colitis-associated Neoplasia

Inflammatory Bowel Diseases

Volumn 22, Issue 9, 2016, Pages 2221-2228

  Jegadeesan, Ramprasad ^a   Navaneethan, Udayakumar ^a,b   Gutierrez, Norma G ^a   Venkatesh, Preethi G K ^a   Hammel, Jeffrey P ^a   Sanaka, Madhusudhan R ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FLORIDA HOSPITAL   (United States)

Author keywords

colonoscopy; dysplasia; surveillance; ulcerative colitis

Indexed keywords

CORTICOSTEROID; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COLON POLYP; COLON STENOSIS; COLON TUMOR; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; GASTROINTESTINAL DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCAR FORMATION; SEX RATIO; SMOKING; ULCERATIVE COLITIS; CASE CONTROL STUDY; COMPLICATION; FACTUAL DATABASE; INFLAMMATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY; SEX FACTOR; STATISTICAL MODEL; UNITED STATES;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; DATABASES, FACTUAL; FEMALE; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MESALAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 84983670646     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000862     Document Type: Article

References (27)

1. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954-960.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
3. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001; 120:1356-1362.
4. Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut. 2001;48:430-434.
5. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis-a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology. 1992;102:1877-1880.
6. Brentnall TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331-338.
7. Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53:1813-1816.
8. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
9. Van Schaik FD, Offerhaus GJ, Schipper ME, et al. Endoscopic and pathological aspects of colitis-associated dysplasia. Nat Rev Gastroenterol Hepatol. 2009;6:671-678.
10. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:204-211.
11. Shanahan F. Relation between colitis and colon cancer. Lancet. 2001;357: 246-247.
12. Lashner BA, Turner BC, Bostwick DG, et al. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci. 1990;35:349-352.
13. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18 (suppl 2):1-5.
14. Beaugerie L, Svrcek M, Seksik P, et al; CESAME Study Group. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166-175.
15. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
16. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639-645.
17. Baars JE, Looman CW, Steyerberg EW, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol. 2011;106:319-328.
18. Gordon IO, Agrawal N, Goldblum JR, et al. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis. 2014;20:2198-2206.
19. Munkholm P, Loftus EV Jr, Reinacher-Schick A, et al. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates 1. Digestion. 2006;73:11-19.
20. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005;100:1345-1353.
21. Bernstein CN, Nugent Z, Blanchard JF. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Am J Gastroenterol. 2011;106:731-736.
22. Terdiman JP, Steinbuch M, Blumentals WA, et al. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:367-371.
23. Zhao L-N, Li J-Y, Yu T, et al. 5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated metaanalysis. PLoS One. 2014;9:e94208.
24. Murphy G, Devesa SS, Cross AJ, et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128: 1668-1675.
25. Pinczowski D, Ekbom A, Baron J, et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994;107:117-120.
26. Laine L, Kaltenbach T, Barkun A, et al; SCENIC Guideline Development Panel. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489-501.
27. Wu L, Li P, Wu J, et al. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis. 2012;14:416-420.